|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
5 months to Dec 31, 2020
|
|
|---|---|---|---|---|
| Cash Flows from Operating Activities: | ||||
| Net (loss) income | ||||
| Adjustments to reconcile net (loss) income to net cash used in operating activities: | ||||
| Interest earned on cash and marketable securities held in Trust account | ||||
| Offering costs allocated to warrants | ||||
| Change in fair value of warrant liability | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses | ||||
| Accrued expenses | ||||
| Due to related party | ||||
| Income tax payable | ||||
| Net cash used in operating activities | ||||
| Cash Flows from Investing Activities: | ||||
| Investment of cash in Trust Account | ||||
| Deposit into Trust account for Extension | ||||
| Cash withdrawn for redemptions | ||||
| Interest withdrawn from Trust account to pay for franchise and federal income taxes | ||||
| Net cash provided by (used in) investing activities | ||||
| Cash Flows from Financing Activities: | ||||
| Proceeds from issuance of founder shares | ||||
| Proceeds from issuance of Units, net of underwriting discount | ||||
| Proceeds from promissory note – related party | ||||
| Proceeds from convertible promissory note – related party | ||||
| Repayment of promissory note – related party | ||||
| Payment of offering costs | ||||
| Redemption of common stock | ||||
| Net cash (used in) provided by financing activities | ||||
| Net change in cash | ||||
| Cash, beginning of year | ||||
| Cash, end of the year | ||||
| Supplemental disclosure of cash flow information: | ||||
| Deferred underwriting commissions payable charged to additional paid in capital | ||||
| Excise tax payable attributable to redemption of common stock | ||||
| Remeasurement of common stock subject to possible redemption to redemption value | ||||
| Taxes paid | ||||
Loading...